Identification of key vaginal microbial signatures and immune remodeling associated with HR-HPV clearance following Kushen Gel treatment: a longitudinal analysis - Scorecard - MDSpire

Identification of key vaginal microbial signatures and immune remodeling associated with HR-HPV clearance following Kushen Gel treatment: a longitudinal analysis

  • By

  • Ying Wang

  • Shuheng Pan

  • Fengying Zhang

  • Huimin Ma

  • Rihan Wu

  • Jing Zhang

  • Xia Li

  • July 2, 2026

  • 0 min

Share

Clinical Scorecard: Characterization of Vaginal Microbial Profiles and Immune Changes Linked to HR-HPV Clearance After Kushen Gel Treatment: A Longitudinal Study

At a Glance

CategoryDetail
ConditionHigh-risk human papillomavirus (HR-HPV) infection
Key MechanismsKushen Gel treatment promotes microbial remodeling and immune shifts, enhancing HR-HPV clearance.
Target PopulationWomen with persistent HR-HPV infection
Care SettingClinical research setting

Key Highlights

  • Kushen Gel treatment resulted in an 82.9% HR-HPV clearance rate after three menstrual cycles.
  • Significant reduction in vaginal pH from 4.85 to 4.12 post-treatment.
  • Post-treatment showed a shift to a Lactobacillus-dominant microbiome.
  • Pro-inflammatory cytokines IL-8, IL-6, and TNF-α significantly decreased.
  • Anti-viral cytokine IFN-γ levels increased significantly in responders.

Guideline-Based Recommendations

Diagnosis

  • Laboratory-confirmed positive HR-HPV DNA for ≥12 months.

Management

  • Kushen Gel treatment for HR-HPV clearance and vaginal dysbiosis.

Monitoring & Follow-up

  • Assess vaginal pH and Nugent scores alongside HR-HPV status.

Risks

  • Persistent HR-HPV infection is associated with cervical carcinogenesis.

Patient & Prescribing Data

Women with persistent HR-HPV infection.

Kushen Gel shows promise in enhancing HR-HPV clearance and restoring vaginal microbiome balance.

Clinical Best Practices

  • Monitor cytokine profiles to assess immune response to treatment.
  • Evaluate changes in vaginal microbiota composition post-treatment.

Related Resources & Content

Original Source(s)

Related Content